Global Clinical Oncology Next Generation Sequencing Market Size study & Forecast, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing) by Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), by Application (Screening, Companion Diagnostics, Others), by End Use (Hospitals, Clinics, Laboratories) and Regional Analysis, 2023-2030
Global Clinical Oncology Next Generation Sequencing Market is valued at approximately USD 370.0 million in 2022 and is anticipated to grow with a healthy growth rate of more than 15.70% over the forecast period 2023-2030. Clinical Oncology Next Generation Sequencing (NGS) refers to the application of advanced genomic sequencing technologies in the field of oncology, specifically for diagnosing and managing cancer. NGS is a high-throughput sequencing technique that enables the simultaneous analysis of multiple genes or genomic regions, providing comprehensive genetic information about a tumor. The Clinical Oncology Next Generation Sequencing market is expanding because of factors such as rising prevelance of cancer disorders, rising investment in research & development activities to invent solutions and growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer.
The increasing prevalence of cancer has spurred a rapid expansion of cancer research initiatives worldwide. NGS technology has become a cornerstone in cancer genomics research, facilitating large-scale genomic studies and collaborative efforts to unravel the complex genetic landscape of various cancer types. These research efforts contribute to the development of novel therapies, identification of new targets, and improved understanding of cancer biology. according to estimates from the International Agency for Research on Cancer (IARC), in year 2021 there were around 1.9 million new cancer cases across the world, and it is projected to increase at 27.5 million new cases by year 2040, worldwide. Moreover, key market players in the market are developing new platforms for the clinical uses of NGS in precision oncology resulting in market growth. For instance, a major company in the industry, In August 2022, Thermo Fisher Scientific launched NGS Analysis and Test Software CE-IVD (IVDD) in order to make precision oncology biomarker testing more widely available. Healthcare professionals can swiftly assess the outcomes of genomic tests thanks to this software. The software evaluates the variation data in light of pertinent data, such as supported recommendations, treatments, clinical studies, and peer-reviewed literature. Such developments in NGS clinical applications may increase consumer demand. In addition, technological advancements in next-generation sequencing (NGS) and growing adoption of companion diagnostics and personalized medicine is creating a lucrative opportunity in the market. However, the lack of computational efficiency for data management stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Clinical Oncology Next Generation Sequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising research and development for precision oncology, rising investment in development of product, and rising government support to the healthcare industry. Asia Pacific is projected to have significant growth in the market space owing to factors such as rising prevelance of cancer, rising healthcare expenditure and rising government investment in oncology drug development activities.
Major market player included in this report are:
Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Beijing Genomics Institute (BGI)
Perkin Elmer, Inc.
Oxford Nanopore Technologies
Paradigm Diagnostics, Inc.
PerkinElmer, Inc.
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing
By Workflow:
NGS Pre-Sequencing
NGS Sequencing
NGS Data Analysis
By Application:
Screening
Companion Diagnostics
Others
By End-use:
Hospitals
Clinics
Laboratories
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The increasing prevalence of cancer has spurred a rapid expansion of cancer research initiatives worldwide. NGS technology has become a cornerstone in cancer genomics research, facilitating large-scale genomic studies and collaborative efforts to unravel the complex genetic landscape of various cancer types. These research efforts contribute to the development of novel therapies, identification of new targets, and improved understanding of cancer biology. according to estimates from the International Agency for Research on Cancer (IARC), in year 2021 there were around 1.9 million new cancer cases across the world, and it is projected to increase at 27.5 million new cases by year 2040, worldwide. Moreover, key market players in the market are developing new platforms for the clinical uses of NGS in precision oncology resulting in market growth. For instance, a major company in the industry, In August 2022, Thermo Fisher Scientific launched NGS Analysis and Test Software CE-IVD (IVDD) in order to make precision oncology biomarker testing more widely available. Healthcare professionals can swiftly assess the outcomes of genomic tests thanks to this software. The software evaluates the variation data in light of pertinent data, such as supported recommendations, treatments, clinical studies, and peer-reviewed literature. Such developments in NGS clinical applications may increase consumer demand. In addition, technological advancements in next-generation sequencing (NGS) and growing adoption of companion diagnostics and personalized medicine is creating a lucrative opportunity in the market. However, the lack of computational efficiency for data management stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Clinical Oncology Next Generation Sequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising research and development for precision oncology, rising investment in development of product, and rising government support to the healthcare industry. Asia Pacific is projected to have significant growth in the market space owing to factors such as rising prevelance of cancer, rising healthcare expenditure and rising government investment in oncology drug development activities.
Major market player included in this report are:
Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Beijing Genomics Institute (BGI)
Perkin Elmer, Inc.
Oxford Nanopore Technologies
Paradigm Diagnostics, Inc.
PerkinElmer, Inc.
Recent Developments in the Market:
- In February 2023, F. Hoffmann-La Roche Ltd. and Janssen Biotech Inc. (Janssen) expanded their collaboration in order to create companion diagnostics for targeted treatments and to include a wide spectrum of companion diagnostics, including tissue- and blood-based biomarkers, digital pathology, and sequencing pathology.
- In June 2023, Illumina Inc., a producer of DNA sequencing and array-based technologies, developed the artificial intelligence system PrimateAI-3D, which had previously unheard-of accuracy in foretelling disease-causing genetic defects in individuals.
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered - Technology, Workflow, Type, End-use, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing
By Workflow:
NGS Pre-Sequencing
NGS Sequencing
NGS Data Analysis
By Application:
Screening
Companion Diagnostics
Others
By End-use:
Hospitals
Clinics
Laboratories
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Clinical Oncology Next Generation Sequencing Market, by Region, 2020-2030 (USD Million)
1.2.2. Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2030 (USD Million)
1.2.3. Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2030 (USD Million)
1.2.4. Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2030 (USD Million)
1.2.5. Clinical Oncology Next Generation Sequencing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET DYNAMICS
3.1. Clinical Oncology Next Generation Sequencing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of cancer
3.1.1.2. Rising investment in research & development activities to invent solutions.
3.1.1.3. Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer.
3.1.2. Market Challenges
3.1.2.1. Lack of computational efficiency for data management
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in next-generation sequencing (NGS)
3.1.3.2. Growing adoption of companion diagnostics and personalized medicine
CHAPTER 4. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Clinical Oncology Next Generation Sequencing Market by Technology, Performance - Potential Analysis
5.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
5.4.1. Whole Genome Sequencing
5.4.2. Whole Exome Sequencing
5.4.3. Targeted Sequencing & Resequencing
CHAPTER 6. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW
6.1. Market Snapshot
6.2. Global Clinical Oncology Next Generation Sequencing Market by Workflow, Performance - Potential Analysis
6.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Workflow 2020-2030 (USD Million)
6.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
6.4.1. NGS Pre-Sequencing
6.4.2. NGS Sequencing
6.4.3. NGS Data Analysis
CHAPTER 7. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Clinical Oncology Next Generation Sequencing Market by Application, Performance - Potential Analysis
7.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
7.4.1. Screening
7.4.2. Companion Diagnostics
7.4.3. Others
CHAPTER 8. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY END-USE
8.1. Market Snapshot
8.2. Global Clinical Oncology Next Generation Sequencing Market by End-use, Performance - Potential Analysis
8.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Laboratories
CHAPTER 9. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Clinical Oncology Next Generation Sequencing Market, Regional Market Snapshot
9.4. North America Clinical Oncology Next Generation Sequencing Market
9.4.1. U.S. Clinical Oncology Next Generation Sequencing Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Workflow breakdown estimates & forecasts, 2020-2030
9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Clinical Oncology Next Generation Sequencing Market
9.5. Europe Clinical Oncology Next Generation Sequencing Market Snapshot
9.5.1. U.K. Clinical Oncology Next Generation Sequencing Market
9.5.2. Germany Clinical Oncology Next Generation Sequencing Market
9.5.3. France Clinical Oncology Next Generation Sequencing Market
9.5.4. Spain Clinical Oncology Next Generation Sequencing Market
9.5.5. Italy Clinical Oncology Next Generation Sequencing Market
9.5.6. Rest of Europe Clinical Oncology Next Generation Sequencing Market
9.6. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Snapshot
9.6.1. China Clinical Oncology Next Generation Sequencing Market
9.6.2. India Clinical Oncology Next Generation Sequencing Market
9.6.3. Japan Clinical Oncology Next Generation Sequencing Market
9.6.4. Australia Clinical Oncology Next Generation Sequencing Market
9.6.5. South Korea Clinical Oncology Next Generation Sequencing Market
9.6.6. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market
9.7. Latin America Clinical Oncology Next Generation Sequencing Market Snapshot
9.7.1. Brazil Clinical Oncology Next Generation Sequencing Market
9.7.2. Mexico Clinical Oncology Next Generation Sequencing Market
9.8. Middle East & Africa Clinical Oncology Next Generation Sequencing Market
9.8.1. Saudi Arabia Clinical Oncology Next Generation Sequencing Market
9.8.2. South Africa Clinical Oncology Next Generation Sequencing Market
9.8.3. Rest of Middle East & Africa Clinical Oncology Next Generation Sequencing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Illumina, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Thermo Fisher Scientific Inc.
10.3.3. F. Hoffmann-La Roche Ltd
10.3.4. Agilent Technologies, Inc.
10.3.5. Myriad Genetics, Inc.
10.3.6. Beijing Genomics Institute (BGI)
10.3.7. Perkin Elmer, Inc.
10.3.8. Oxford Nanopore Technologies
10.3.9. Paradigm Diagnostics, Inc.
10.3.10. PerkinElmer, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Clinical Oncology Next Generation Sequencing Market, report scope
TABLE 2. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 4. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Workflow 2020-2030 (USD Million)
TABLE 5. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 6. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by End-use 2020-2030 (USD Million)
TABLE 7. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 21. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 24. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 27. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 30. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 33. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 36. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 39. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 42. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 45. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 48. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 51. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 54. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 57. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 60. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 63. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 66. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. Saudi Arabia Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 69. South Africa Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. RoMEA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. List of secondary sources, used in the study of global Clinical Oncology Next Generation Sequencing Market
TABLE 72. List of primary sources, used in the study of global Clinical Oncology Next Generation Sequencing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Clinical Oncology Next Generation Sequencing Market, research methodology
FIG 2. Global Clinical Oncology Next Generation Sequencing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Clinical Oncology Next Generation Sequencing Market, key trends 2022
FIG 5. Global Clinical Oncology Next Generation Sequencing Market, growth prospects 2023-2030
FIG 6. Global Clinical Oncology Next Generation Sequencing Market, porters 5 force model
FIG 7. Global Clinical Oncology Next Generation Sequencing Market, pest analysis
FIG 8. Global Clinical Oncology Next Generation Sequencing Market, value chain analysis
FIG 9. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Clinical Oncology Next Generation Sequencing Market, regional snapshot 2020 & 2030
FIG 15. North America Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 16. Europe Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 18. Latin America Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Clinical Oncology Next Generation Sequencing Market, by Region, 2020-2030 (USD Million)
1.2.2. Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2030 (USD Million)
1.2.3. Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2030 (USD Million)
1.2.4. Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2030 (USD Million)
1.2.5. Clinical Oncology Next Generation Sequencing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET DYNAMICS
3.1. Clinical Oncology Next Generation Sequencing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of cancer
3.1.1.2. Rising investment in research & development activities to invent solutions.
3.1.1.3. Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer.
3.1.2. Market Challenges
3.1.2.1. Lack of computational efficiency for data management
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in next-generation sequencing (NGS)
3.1.3.2. Growing adoption of companion diagnostics and personalized medicine
CHAPTER 4. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Clinical Oncology Next Generation Sequencing Market by Technology, Performance - Potential Analysis
5.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
5.4.1. Whole Genome Sequencing
5.4.2. Whole Exome Sequencing
5.4.3. Targeted Sequencing & Resequencing
CHAPTER 6. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW
6.1. Market Snapshot
6.2. Global Clinical Oncology Next Generation Sequencing Market by Workflow, Performance - Potential Analysis
6.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Workflow 2020-2030 (USD Million)
6.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
6.4.1. NGS Pre-Sequencing
6.4.2. NGS Sequencing
6.4.3. NGS Data Analysis
CHAPTER 7. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Clinical Oncology Next Generation Sequencing Market by Application, Performance - Potential Analysis
7.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
7.4.1. Screening
7.4.2. Companion Diagnostics
7.4.3. Others
CHAPTER 8. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY END-USE
8.1. Market Snapshot
8.2. Global Clinical Oncology Next Generation Sequencing Market by End-use, Performance - Potential Analysis
8.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Laboratories
CHAPTER 9. GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Clinical Oncology Next Generation Sequencing Market, Regional Market Snapshot
9.4. North America Clinical Oncology Next Generation Sequencing Market
9.4.1. U.S. Clinical Oncology Next Generation Sequencing Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Workflow breakdown estimates & forecasts, 2020-2030
9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Clinical Oncology Next Generation Sequencing Market
9.5. Europe Clinical Oncology Next Generation Sequencing Market Snapshot
9.5.1. U.K. Clinical Oncology Next Generation Sequencing Market
9.5.2. Germany Clinical Oncology Next Generation Sequencing Market
9.5.3. France Clinical Oncology Next Generation Sequencing Market
9.5.4. Spain Clinical Oncology Next Generation Sequencing Market
9.5.5. Italy Clinical Oncology Next Generation Sequencing Market
9.5.6. Rest of Europe Clinical Oncology Next Generation Sequencing Market
9.6. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Snapshot
9.6.1. China Clinical Oncology Next Generation Sequencing Market
9.6.2. India Clinical Oncology Next Generation Sequencing Market
9.6.3. Japan Clinical Oncology Next Generation Sequencing Market
9.6.4. Australia Clinical Oncology Next Generation Sequencing Market
9.6.5. South Korea Clinical Oncology Next Generation Sequencing Market
9.6.6. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market
9.7. Latin America Clinical Oncology Next Generation Sequencing Market Snapshot
9.7.1. Brazil Clinical Oncology Next Generation Sequencing Market
9.7.2. Mexico Clinical Oncology Next Generation Sequencing Market
9.8. Middle East & Africa Clinical Oncology Next Generation Sequencing Market
9.8.1. Saudi Arabia Clinical Oncology Next Generation Sequencing Market
9.8.2. South Africa Clinical Oncology Next Generation Sequencing Market
9.8.3. Rest of Middle East & Africa Clinical Oncology Next Generation Sequencing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Illumina, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Thermo Fisher Scientific Inc.
10.3.3. F. Hoffmann-La Roche Ltd
10.3.4. Agilent Technologies, Inc.
10.3.5. Myriad Genetics, Inc.
10.3.6. Beijing Genomics Institute (BGI)
10.3.7. Perkin Elmer, Inc.
10.3.8. Oxford Nanopore Technologies
10.3.9. Paradigm Diagnostics, Inc.
10.3.10. PerkinElmer, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Clinical Oncology Next Generation Sequencing Market, report scope
TABLE 2. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Technology 2020-2030 (USD Million)
TABLE 4. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Workflow 2020-2030 (USD Million)
TABLE 5. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 6. Global Clinical Oncology Next Generation Sequencing Market estimates & forecasts by End-use 2020-2030 (USD Million)
TABLE 7. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Clinical Oncology Next Generation Sequencing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. Global Clinical Oncology Next Generation Sequencing Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 18. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. U.S. Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 21. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. Canada Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 24. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. UK Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 27. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. Germany Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 30. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. France Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 33. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Italy Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 36. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. Spain Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 39. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. RoE Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 42. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. China Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 45. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. India Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 48. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. Japan Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 51. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. South Korea Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 54. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. Australia Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 57. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. RoAPAC Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 60. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Brazil Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 63. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. Mexico Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 66. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. RoLA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. Saudi Arabia Clinical Oncology Next Generation Sequencing Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 69. South Africa Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. RoMEA Clinical Oncology Next Generation Sequencing Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 71. List of secondary sources, used in the study of global Clinical Oncology Next Generation Sequencing Market
TABLE 72. List of primary sources, used in the study of global Clinical Oncology Next Generation Sequencing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Clinical Oncology Next Generation Sequencing Market, research methodology
FIG 2. Global Clinical Oncology Next Generation Sequencing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Clinical Oncology Next Generation Sequencing Market, key trends 2022
FIG 5. Global Clinical Oncology Next Generation Sequencing Market, growth prospects 2023-2030
FIG 6. Global Clinical Oncology Next Generation Sequencing Market, porters 5 force model
FIG 7. Global Clinical Oncology Next Generation Sequencing Market, pest analysis
FIG 8. Global Clinical Oncology Next Generation Sequencing Market, value chain analysis
FIG 9. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Clinical Oncology Next Generation Sequencing Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Clinical Oncology Next Generation Sequencing Market, regional snapshot 2020 & 2030
FIG 15. North America Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 16. Europe Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 18. Latin America Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Clinical Oncology Next Generation Sequencing Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
